Valuation: Dechra Pharmaceuticals

Market Cap 4.4B 5.83B 5.11B 4.72B 8.29B 552B 8.48B 56.75B 21.91B 272B 21.91B 21.43B 945B P/E 2022
64.8x
P/E 2023 -150x
Enterprise Value 4.83B 6.4B 5.61B 5.18B 9.1B 605B 9.31B 62.29B 24.05B 299B 24.05B 23.52B 1,037B EV / Sales 2022
5.8x
EV / Sales 2023 6.08x
Free-Float
-
Yield 2022
1.3%
Yield 2023 0.34%
3 years 3,644
Extreme 3644
4,145.84
5 years 2,473.32
Extreme 2473.323
5,525
10 years 1,119
Extreme 1119
5,525
Manager TitleAgeSince
Chief Executive Officer - 09/06/2024
Director of Finance/CFO 46 02/04/2019
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 46 29/10/2019
Director/Board Member 68 30/11/2016
Director/Board Member 59 31/01/2019
Date Insider Type Main position Quantity % Market Cap.
14/01/24Free

Chief Executive Officer

3,580 0.0031%
14/01/24Free

Chief Financial Officer

2,335 0.0021%
14/01/24Free

Chief Financial Officer

8,600 0.0076%

Financials

2022 2023
Net sales 682M 903M 791M 730M 1.28B 85.4B 1.31B 8.79B 3.39B 42.13B 3.39B 3.32B 146B 762M 1.01B 883M 815M 1.43B 95.38B 1.47B 9.81B 3.79B 47.05B 3.79B 3.71B 163B
Net income 58.2M 77.1M 67.51M 62.33M 110M 7.29B 112M 750M 290M 3.6B 290M 283M 12.49B -27.9M -36.96M -32.36M -29.88M -52.52M -3.49B -53.72M -360M -139M -1.72B -139M -136M -5.99B
Net Debt 208M 276M 242M 223M 392M 26.08B 401M 2.68B 1.04B 12.86B 1.04B 1.01B 44.67B 430M 570M 499M 461M 810M 53.87B 828M 5.54B 2.14B 26.58B 2.14B 2.09B 92.27B
Logo Dechra Pharmaceuticals
Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows: - companion animal products (74.6%); - food producing animal products (11.5%); - equine health products (7.3%); - animal feeds (5.1%); - other (1.5%): products manufactured by third parties. Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).
Employees
-
Sector
-